Aelin Therapeutics

Foundation date

06/12/2017

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Aelin Therapeutics is a biopharmaceutical company that has secured a 27 M€ investment to pioneer
peptide-based novel modalities to create a powerful first-in-class antibiotics and agents against high value undruggable human targets. 

Upcoming events

Latest news

  • Scipher Medicine and Galapagos sign collaboration in inflammatory bowel disease

    1 day ago

  • Bone Therapeutics receives EUR 1.0 million to advance ongoing JTA-004 phase III knee osteoarthritis study

    1 day ago

  • BISC Global opens in Switzerland

    Wednesday August 12th 2020

Jobs by Aelin Therapeutics